tert-Butyldimethyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)silane, 98+%, 25g

6-Chloro-3-hydroxypyridazine, 99.00%, 25g

(S)-7-CHLOROCHROMAN-4-AMINE HCL, 95%, 250mg

2-(4,4-Dimethylcyclohexyl)acetic acid, 97%, 250mg

Acetonitril, min. 99,5 %, zur Synthese, 1 l, Glasverpackung

Benzo[1,2-b:4,5-b']dithiophene-4,8-dione, 95.0%, 100g

(11bR)-N,N-Bis((S)-1-phenylethyl)-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]di-oxaphosphepin-4-amine, 97%, 250mg

5-Hydroxynicotinaldehyde, 95.0%, 5g

5-(3-Chloro-pyridin-2-yl)-1-methyl-1H-pyrazole-4-carboxylic acid ethyl ester, 95.0%, 1g

1-Bromo-3-ethoxy-4-methylbenzene, 97.0%, 5g

2-(Benzyloxy)-4-bromophenol, 97.0%, 25g

2-morpholin-4-yl-7-(2-thienyl)[1,3]thiazolo[4,5-d]pyridazin-4(5H)-one, 95.0%, 250mg

tert-Butyl 4-(4-Aminophenyl)piperidine-1-carboxylate>97.0%(HPLC)1g